XML 29 R17.htm IDEA: XBRL DOCUMENT v3.25.3
OTHER ASSETS
 9 Months Ended
Sep. 30, 2025
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
OTHER ASSETS
NOTE 9—OTHER ASSETS

The following is a summary of our Other assets (dollars in thousands):

As of September 30, 2025As of December 31, 2024
Straight-line rent receivables$242,762 $202,675 
Deferred lease costs, net154,181 145,973 
Accounts receivable, net (1)
92,463 108,138 
Investment in unconsolidated operating entities97,904 95,623 
Prepaid assets
90,505 71,786 
Non-mortgage loans receivable, net
20,871 28,129 
Other intangibles, net10,903 11,513 
Other (2)
94,930 128,826 
Total Other assets
$804,519 $792,663 
_____________________________
(1)    Allowance for doubtful accounts as of September 30, 2025 and December 31, 2024 were $74.7 million and $70.3 million, respectively.
(2)    The balance as of September 30, 2025 included, among other items, stock warrants exercisable at any time prior to September 13, 2034 for 9.9% of the common equity of a parent company of Kindred Healthcare, LLC (together with its subsidiaries, “Kindred”) at the pre-transaction value of such common equity (the “Scion Warrants”). The balance as of December 31, 2024 included, among other items, the Scion warrants as well as stock warrants exercisable at any time prior to December 31, 2025, in whole or in part, for 11.1 million shares of Brookdale Senior Living, Inc. common stock (“Brookdale Common Stock”) at an exercise price of $3.00 per share (the “Brookdale Warrants”). During the nine months ended September 30, 2025, we exercised all remaining 11.1 million Brookdale Warrants on a cashless basis (net of the $3.00 exercise price), resulting in Ventas receiving 5.7 million net shares of Brookdale Common Stock, which we sold for net cash proceeds of approximately $35.6 million (recorded within operating cash flows in our Consolidated Statements of Cash Flows). The Brookdale Warrants and the Scion Warrants were measured at fair value with changes in fair value being recognized within Other expense in our Consolidated Statements of Income.